U.K.-based Ultromics announced it received FDA Breakthrough Device Designation for an AI tool that aims to detect cardiac amyloidosis.
The platform, called EchoGo Amyloidosis, analyzes echocardiograms to find signs of the condition, where the protein amyloid builds up in the heart and limits function. Though the designation isn’t a marketing approval from the FDA, it aims to accelerate review of...
UK-based Ultromics announced Tuesday that its machine learning-based decision-support system used to help detect heart failure with preserved ejection fraction had received FDA 510(k) clearance.
EchoGo Heart Failure, which was developed in partnership with the Mayo Clinic, aids physicians in diagnosing the condition by providing them with echocardiogram imaging results in people over 25 years old...
UK-based health tech firm Ultromics and Caption Health today announced a partnership to accelerate cardiovascular disease detection and treatment for more patients in accessible care settings.
The companies, which both specialise in using AI to improve heart ultrasound diagnostics, will offer Caption Health’s AI software platform alongside Ultromics’ EchoGo deep ultrasound analytics.
Through the...
Ultromics, maker of AI-supported cardiac imaging tools, announced Monday it has raised $33 million in Series B funding.
The funding round was led by Blue Venture Fund, a group of Blue Cross Blue Shield insurers, the Blue Cross Blue Shield Association and venture capital firm Sandbox. Optum Ventures, GV and existing investor Oxford Sciences Innovation also participated.
The UK-based health tech...
A research programme led by US-based non-profit medical centre Mayo Clinic and UK health tech firm Ultromics will apply AI to forecast heart failure.
The team will use AI analysis of ultrasound heart scans to identify the markers of heart failure and alert doctors to potential heart failure.
WHY IT MATTERS
The aim is to develop a diagnostic and predictive tool that can reduce misdiagnosis and...
On Monday Ultromics, maker of an AI-supported cardiac-decision-support tool, scored $10 million in funding. Oxford Sciences Innovation led the round with participation from Mayo Clinic.
This comes just two years after the startup scored £10m in a Series A round also led by Oxford Sciences Innovation.
WHAT THEY DO
Founded in 2017, this Oxford University spinout is currently focused on creating...
British health tech firm Mindwave Ventures has announced this morning that it plans to open an office in Leeds, one of the biggest cities in the UK, after appointing Dr Victoria Betton and Dr Janak Gunatilleke to the roles of chief innovation officer and chief operating officer, respectively.
Since its founding in 2014, the company has worked with six NHS trusts and a sustainability and...
UK-based health technology firm Ultromics has received clearance from the US Food and Drug Administration (FDA) for its cardiovascular image analysis system, EchoGo Core.
EchoGo applies artificial intelligence (AI) to automate the analysis and quantification of ultrasound-based heart scans.
The 510 (K) clearance, pre-market submission, will enable the business to make EchoGo available to...
